Pre-clinical Evaluation of Karan** Against DMBA-Induced Breast Cancer in Female Sprague–Dawley Rats Through Modulation of SMAR1 and CDP/CUx genes

P Tirgar, M Vekaria, K Raval - Naunyn-Schmiedeberg's Archives of …, 2024 - Springer
Purpose To investigate the chemoprotective potential of karan** against 7, 12-dimethylbenz
(α) anthracene (DMBA)-induced breast cancer. Methodology Thirty-six female rats were …

Karan**, A Promising Bioactive Compound Possessing Anti-cancer Activity against Experimental Model of Non-small Cell Lung Cancer Cells

G Kumar, DM Pandey, M Ghosh… - Anti-Cancer Agents …, 2024 - benthamdirect.com
Aims: The aim of this study is to isolate the Millettia pinnata (Karanj) leaf extract for pure
compound with anticancer properties and to study the molecular target of the isolates in non …

Investigation into the potential mechanism and therapeutic targets of Cangzhu Erchen decoction for the treatment of chronic obstructive pulmonary disease based on …

X Gu, J Ju, Q Chen, M Ge, H Huang - Medicine, 2024 - journals.lww.com
This study aimed to elucidate the molecular mechanisms underlying the therapeutic effects
of Cangzhu Erchen decoction (CZECD) in the treatment of chronic obstructive pulmonary …